3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
26
Pancreatic Neoplasms
11
Stomach Neoplasms
10
Rectal Neoplasms
10
Colonic Neoplasms
10
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Neoplasms
5
Cholangiocarcinoma
5
Carcinoma, Non-Small-Cell Lung
5
Adenocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Squamous Cell Carcinoma of Head and Neck
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Interventions
Cyclophosphamide
11
fludarabine phosphate
8
Nivolumab
8
pembrolizumab
7
fludarabine
7
Mycophenolic Acid
6
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Doxorubicin
6
Dacarbazine
6
Brentuximab Vedotin
6
Whole-Body Irradiation
5
Vinblastine
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Specimen Handling
4
Melphalan
4
Etoposide
4
Busulfan
4
pegfilgrastim
3
Tacrolimus
3
Radiotherapy
3
Thiotepa
2
Sirolimus
2
Radiation
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Cyclosporins
2
Clofarabine
2
Azacitidine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Fluorouracil
×
30 days
×
Clear all
No trials found.